Jeffrey R Schriber MD
Clinical Professor, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope
Join to View Full Profile
10460 N 92nd StSte 200Scottsdale, AZ 85258
Phone+1 480-323-1573
Fax+1 480-323-1375
Dr. Schriber is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Toronto Faculty of MedicineClass of 1986
Stanford Health CareFellowship, Blood & Bone Marrow Transplant
University of TorontoResidency, Internal Medicine- University of TorontoFellowship, Internal Medicine, Toronto Canada, Royal College of Physicians and Surgeons Canada
- University of TorontoFellowship, Hematology. Toronto Canada. Royal College of Physicians and Surgeons, Canada
Certifications & Licensure
AZ State Medical License 1997 - 2026
CA State Medical License 1998 - 2025
NM State Medical License 2022 - 2025
ID State Medical License 2023 - 2024
OK State Medical License 2023 - 2024
NY State Medical License 1994 - 1998
Canada's Royal College of Physicians and SurgeonsHematology- Canada's Royal College of Physicians and SurgeonsInternal Medicine
Clinical Trials
- Stem Cell Transplantation in Individuals With Multiple Myeloma (BMT CTN 0102) Start of enrollment: 2003 Dec 01
- A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- A Study That Switched Patients From Imatinib to Nilotinib and Then Was Followed by Treatment Cessation Start of enrollment: 2013 Aug 12
- Join now to see all
Publications & Presentations
PubMed
- 17 citationsCharacteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD Prophylaxis.Rima M Saliba, Amin M Alousi, Joseph Pidala, Mukta Arora, Stephen R Spellman
Transplantation and Cellular Therapy. 2022-10-01 - 3 citationsA prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemiaJoshua F. Zeidner, Tara L. Lin, Carlos E. Vigil, Gil Fine, M. Yair Levy
Blood Cancer Journal. 2021-10-30 - Correction to: Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era.Binod Dhakal, Sagar Patel, Saulius Girnius, Lohith Bachegowda, Raphael Fraser
Leukemia. 2021-07-01
Press Mentions
A Comprehensive Guide to Understanding Blood CancersNovember 2nd, 2017
Could Common Diabetes Drugs Help Fight Leukemia?September 2nd, 2015
What Is Hairy Cell Leukemia? Experts Explain This Rare Type of CancerSeptember 11th, 2021- Join now to see all
Professional Memberships
- Member
- American Society for Blood and Marrow TransplantationMember
- Member
- Member
- Canadian Medical AssociationMember
- Royal College of Physicians and SurgeonsMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
